Covid-19

A teenager in British Columbia is in critical condition after contracting what is believed to be Canada's first human case of the bird flu. The teen, previously healthy with no underlying conditions, has rapidly deteriorated due to avian influenza, health officials announced this week. Provincial...

On Wednesday, Ark Invest, led by Cathie Wood, made significant trades in Moderna Inc. (NASDAQ:MRNA) and Square Inc. (NYSE:SQ). The Moderna Trade Ark Invest removed 49,922 shares of Moderna Inc. (NASDAQ:MRNA) from its ARK Genomic Revolution ETF (BATS:ARKG) on Wednesday. The trade is estimated to be...

Northwestern University has filed a patent infringement lawsuit against Moderna, Inc. (NASDAQ:MRNA), alleging the pharmaceutical company used the university’s lipid nanoparticle (LNP) technology without permission to develop its COVID-19 vaccines. According to the lawsuit, the development of...

On Wednesday, Cathie Wood’s Ark Invest made significant trades involving Block Inc (NYSE:SQ) and Moderna Inc (NASDAQ:MRNA). The SQ Trade Ark Invest sold off a significant amount of shares in the Jack Dorsey-led Block, despite the Bitcoin (CRYPTO: BTC)-focused company’s recent positive...

On Wednesday, major U.S. indices saw gains, with the Dow Jones Industrial Average climbing nearly 0.8% to 43,077.70, while the S&P 500 increased 0.5% to 5,842.47. The Nasdaq finished the day up almost 0.3% at 18,367.08. These are the top stocks that gained the attention of retail traders and...

On Thursday, Cathie Wood-led Ark Invest made a significant move by offloading shares of Moderna Inc (NASDAQ:MRNA). This decision comes amidst a backdrop of mixed analyst sentiments and Moderna’s recently unveiled post-COVID roadmap. The Moderna Trade Ark Invest’s ARK Genomic Revolution...

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) and Moderna, Inc. (NASDAQ:MRNA) have reached a stipulation in their ongoing patent infringement litigation. In 2022, Alnylam filed a patent infringement lawsuit against Moderna, claiming it violated a newly obtained patent. The claim is over mRNA...

Gilead Sciences Inc. (NASDAQ:GILD) has voluntarily recalled one lot of its COVID-19 treatment, Veklury (remdesivir), for Injection 100 mg/vial, after discovering glass particles in the vials. The company received a customer complaint that prompted an investigation, confirming the presence of...

In their first debate for the 2024 election, Vice President Kamala Harris criticized former President Donald Trump for severe unemployment during his tenure, as well as his economic policies and handling of the COVID-19 pandemic. What Happened: “Donald Trump left us the worst unemployment...

Each week, Benzinga's Stock Whisper Index uses a combination of proprietary data and pattern recognition to showcase five stocks that are just under the surface and deserve attention. Investors are constantly on the hunt for undervalued, under-followed and emerging stocks. With...

Biotech entrepreneur and former GOP presidential candidate, Vivek Ramaswamy, took to X on Tuesday to express his admiration for Mark Zuckerberg, who he says has admitted his mistake by acknowledging censorship on his platform. What Happened: Ramaswamy’s post follows Meta CEO Zuckerberg’...

Starting in late September, U.S. households can order up to four COVID-19 nasal swab tests when the federal program reopens. The exact date for ordering has not been announced, according to the official website, COVIDtests.gov. The U.S. Department of Health and Human Services (HHS), which oversees...

Thursday, the FDA granted emergency use authorization (EUA) for updated mRNA COVID-19 vaccines (2024-2025 formula) to include a monovalent (single) component that corresponds to the Omicron variant KP.2 strain of SARS-CoV-2. The approval comes for the updated vaccines from Moderna Inc (NASDAQ:MRNA...

The U.S. Food and Drug Administration (FDA) may approve updated COVID-19 vaccines this week to combat recent strains as the country endures its most significant summer outbreak in two years. The FDA is expected to give the nod to updated mRNA vaccines from Moderna, Inc. (NASDAQ:MRNA) and Pfizer Inc...

Long Covid continues to evade clear diagnostic testing, as researchers from the National Institute of Health’s RECOVER Initiative revealed in a study published in the Annals of Internal Medicine. Despite examining data from over 10,000 patients across 83 clinical sites, the study found no...